18 June 2018 - A bipartisan group of senators is asking the head of the FDA to provide recommendations to Congress on how to address nationwide drug shortages.

Sens. Chris Murphy and Bill Cassidy led a letter to FDA Commissioner Scott Gottlieb. They, along with 29 of their Senate colleagues, asked the agency to convene its Drug Shortages Task Force in an effort to determine the causes of these shortages and craft policy recommendations on how to fix them by no later than the end of 2019.

Specifically, the letter mentions drug shortages for some routinely used medications, such as local anaesthetics and sterile IV fluids, the latter of which is used to deliver nearly every drug in an emergency or surgical setting.

Read The Hill article